These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21073140)

  • 21. Congenital toxoplasmosis: is screening desirable?
    Foulon W
    Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxoplasmosis prevention knowledge among pregnant women in Minnesota.
    Ogunmodede F; Scheftel J; Jones JL; Lynfield R
    Minn Med; 2005 Feb; 88(2):32-4. PubMed ID: 17886796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of toxoplasmosis in the U.K.
    Joynson DH
    Scand J Infect Dis Suppl; 1992; 84():65-9. PubMed ID: 1290077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasmosis-related knowledge and practices among pregnant women in the United States.
    Jones JL; Ogunmodede F; Scheftel J; Kirkland E; Lopez A; Schulkin J; Lynfield R
    Infect Dis Obstet Gynecol; 2003; 11(3):139-45. PubMed ID: 15022874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital toxoplasmosis].
    Hrnjaković-Cvjetković I; Jerant-Patić V; Cvjetković D; Mrdja E; Milosević V
    Med Pregl; 1998; 51(3-4):140-5. PubMed ID: 9611957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fetal toxoplasmosis: diagnosis and treatment].
    Marrakchi Z; Chaker E; Marrakchi O; Khrouf N
    Tunis Med; 1996; 74(8-9):331-5. PubMed ID: 9506084
    [No Abstract]   [Full Text] [Related]  

  • 27. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling.
    Dunn D; Wallon M; Peyron F; Petersen E; Peckham C; Gilbert R
    Lancet; 1999 May; 353(9167):1829-33. PubMed ID: 10359407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003.
    Berger F; Goulet V; Le Strat Y; Desenclos JC
    Rev Epidemiol Sante Publique; 2009 Aug; 57(4):241-8. PubMed ID: 19577390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seroepidemiology of toxoplasmosis in pregnant women since the implementation of the Surveillance Program of Toxoplasmosis Acquired in Pregnancy and Congenital in the western region of Paraná, Brazil].
    Bittencourt LH; Lopes-Mori FM; Mitsuka-Breganó R; Valentim-Zabott M; Freire RL; Pinto SB; Navarro IT
    Rev Bras Ginecol Obstet; 2012 Feb; 34(2):63-8. PubMed ID: 22437764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The rates of seropositivity and seroconversion of toxoplasma infection in pregnant women].
    Doğan K; Kafkaslı A; Karaman U; Atambay M; Karaoğlu L; Colak C
    Mikrobiyol Bul; 2012 Apr; 46(2):290-4. PubMed ID: 22639318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Toxoplasmosis. The most common parasitic infection in Europe, but not fully understood and probably underdiagnosed].
    Evengård B; Forsgren M; Uggla A
    Lakartidningen; 1997 Sep; 94(38):3249-54. PubMed ID: 9379791
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxoplasma infestation: prevalence, risk of congenital infection and development in Geneva from 1973 to 1987].
    Bornand JE; Piguet JD
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):21-9. PubMed ID: 1990419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the possibilities for preventing congenital toxoplasmosis.
    Foulon W; Naessens A; Derde MP
    Am J Perinatol; 1994 Jan; 11(1):57-62. PubMed ID: 8155214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for Toxoplasma gondii infection in the United States.
    Jones JL; Dargelas V; Roberts J; Press C; Remington JS; Montoya JG
    Clin Infect Dis; 2009 Sep; 49(6):878-84. PubMed ID: 19663709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population.
    Nowakowska D; Stray-Pedersen B; Spiewak E; Sobala W; Małafiej E; Wilczyński J
    Clin Microbiol Infect; 2006 Sep; 12(9):913-7. PubMed ID: 16882298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Toxoplasmosis in Poznan region, Poland 1990-2000].
    Pawłowski ZS
    Przegl Epidemiol; 2002; 56(3):409-17. PubMed ID: 12608090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
    Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
    Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immune response and diagnostic aspects during Toxoplasma gondii infection].
    Lipska A; Wysocka J; Turowski D
    Wiad Parazytol; 2000; 46(3):315-25. PubMed ID: 16883686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Control of congenital toxoplasmosis in Italy: The project of the Istituto Superiore di Sanità].
    Angelici MC; Buffolano W; Grandolfo ME; Gramiccia M; Majori G
    Ann Ist Super Sanita; 1999; 35(2):329-33. PubMed ID: 10645668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.